Multi-stakeholder reports and materials on the practical application of MMC with collaboration from builders, engineers, designers, suppliers, and integrators, will enable everyone to be heard and shape the change.. 5.
shares his insights on the pivotal role of miniaturisation and automation in shaping the future of Active Pharmaceutical Ingredients (APIs) production, highlighting the potential for significant industry transformation.. Watch now for a unique perspective on how modern advancements are paving the way for a new era in pharmaceuticals, not only redefining manufacturing processes but also promising a healthier future for all.Presented by our Head of Sustainability, Helen Hough, this video takes you on a journey through the development of The Forge, a landmark London project that represents a significant leap in sustainable construction..Discover the pioneering use of a platforms approach to Design for Manufacture and Assembly (P-DfMA) and how it contributed to a remarkable reduction in whole-life carbon emissions..
Through Helen's expert insights, learn about the collaborative efforts and innovative strategies that make The Forge a model for future construction projects aiming for environmental excellence.Through this 'In Short' episode,.delves into the challenges and breakthroughs in pharmaceutical manufacturing, exploring how new approaches like process intensification, automation, and continuous processing can lead to more agile, cost-effective, and environmentally friendly production methods.. Click the 'play button' above to listen in, or read our 5 Key Takeaways from this episode below.... 1.Revolution in small molecule API production:.
The episode highlights the transformative research and development in small molecule Active Pharmaceutical Ingredients, emphasising the generation of new, more complex, and targeted molecules.This revolution is pivotal for advancing the mainstay of essential medicines globally.. 2.
Challenges in traditional manufacturing:.
Adrian La Porta discusses the limitations of current manufacturing practices, particularly batch chemistry, in meeting the modern demands for higher volumes, complex products, and faster production at lower costs, all while minimising environmental impact.So you could say you want speed, but unless you change the contract, the risk management profile, the processes - in order to achieve speed, instead of what you do every single day - you're not going to get speed.”.
It’s a fundamental issue and if we truly want to realise the potential industrialised construction has to offer, we need to address it.. “We rarely change the entropy of processes and behaviours around the good idea,” says Amy Marks.“That's why it doesn't happen, not because it's not a good idea.
It's just everything works against it…”.One challenge relates to the complexity of the construction ecosystem itself, which is made up of multiple different industries, all with different value propositions.
(Editor: Simple Gimbals)